甘肃陇神戎发药业股份有限公司

Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd. is a holding subsidiary of Gansu Pharmaceutical Investment Group Co., Ltd. (state-owned enterprise of Gansu Province), a company listed on the Growth Enterprise Market (stock abbreviation: Longshenrongfa; stock code: 300534), a high-tech enterprise integrating the research and development of new medicines, processing of TCM and production and operation, and an enterprise among the first backbone enterprises in strategic emerging industries. Under it there are 3 subsidiaries, namely Gansu Shenkang Pharmaceutical Technology Co., Ltd., Gansu New Silk Road Industrial Investment Co., Ltd. and Lanzhou Sanyuan Pharmaceutical Co., Ltd. The new modern production lines of TCM of the company all pass the GMP certification of the state, with 4 national unique products (Yuanhu Zhitong Diwan, Sinage Yaomo, Suanzaoren You Diwan and Qiwei Wenyang Jiaonang) and 12 OTC products, including Maxing Zhike Jiaonang, Xiaoyan Lidan Pian, Fufang Danshen Pian and Xiaoshuan Tongluo Pian. 3 medicines are listed in the National Essential Medicine List (2012), 4 medicines are listed in OTC Class A products and 5 medicines are listed in the Directory of Drugs Covered by National Basic Medical Insurance, Employment Injury Insurance and Maternity Insurance (2017) Its main product Yuanhu Zhitong Diwan was elected as national key new product in 2012, awarded second prize for technical advancement of Gansu Province in 2013, and was consecutively listed in the National Essential Medicine List (2009, 2012 and 2015). Since 2013, the sales revenue of this product has exceeded RMB 200 million. For many years, Longshenrongfa has adhered to the operation philosophy of " producing good medicines in all conscience", stuck to innovation and development and striven to become an enterprise with a large number of talents. It has established an innovative operation management team led by leading talents and young innovative talents of Gansu Province. The company has successively won more than 20 honors and titles, including enterprise with level AA quality credit of Gansu Province, second prize for technical advancement of Gansu Province and "May Day" labor prize of Gansu Province. It has successively established many technical platforms, including Enterprise Technical Center of Gansu Province and New TCM Dosage Form Research Project Lab of Gansu Province. The trademark "Longshen" has successively been certified as "famous trademark of Gansu Province" and "famous trademark of China". In the future, Longshenrongfa will always adhere to the development philosophy of "promoting TCM culture, inheriting TCM essence and making innovation in TCM industry", rely on the genuine medicinal material resources of Gansu, take advantage of its unique product, integrate industrial resources, improve product structure, extend the industrial chain, and build the company into the vanguard of pharmaceutical industry in Gansu with complete industrial chain, integrating standard planting of Chinese medicinal materials, further processing of Chinese medicinal materials, research and development of new medicines, production of modern TCM, trading and logistics of medicines.